Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Detect Genomix, operated by GeneDx (subsidiary of OPKO Health), provides nationwide next-generation sequencing and genomic diagnostic services, primarily for neonatal intensive care units through a major partnership with Pediatrix Medical Group. Their services are accessible to hospitals and patients nationwide, focusing on rapid, comprehensive genetic diagnoses for critically ill newborns and supporting a broad spectrum of genetic disorders in pediatric care. No specific clinical trial outcomes are disclosed, as the platform focuses on clinical diagnostics, not therapeutic interventions[3].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Detect Genomix.